Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye

ClinicalTrials.gov ID: NCT03982368

Public ClinicalTrials.gov record NCT03982368. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 5:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 4 Weeks, Phase II, Multicenter, Randomized, Double-masked, Vehicle-controlled, Parallel Group Study With 12 Weeks of Follow-up to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution vs Vehicle in Moderate to Severe Dry Eye.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to assess the efficacy and safety of rhNGF eye drops at 20 μg/ml concentration administered two or three times daily for 4 weeks in patients with moderate to severe dry eye.

Study identification

NCT ID
NCT03982368
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Dompé Farmaceutici S.p.A
Industry
Enrollment
261 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 10, 2019 (Actual)
Primary completion
Jul 15, 2020 (Actual)
Completion
Jul 15, 2020 (Actual)
Last update posted
Apr 19, 2024

2019 – 2020

United States locations

U.S. sites
12
U.S. states
7
U.S. cities
10
Facility City State ZIP Site status
Global Research Management Glendale California 91204 —
Eye Research Foundation Newport Beach California 92663 —
Martel Eye Medical Group Rancho Cordova California 95670 —
Sierra Clinical Trials & Research Organization Santa Ana California 92647 —
Clayton Eye Clinical Research, LLC Morrow Georgia 30260 —
Kentucky Eye Institute Lexington Kentucky 40517 —
Tauber Eye Center Kansas City Missouri 64111 —
Moyes Eye Center Kansas City Missouri 64154 —
SightMD Babylon New York 11702 —
Toyos Clinic Nashville Tennessee 37027 —
Houston Eye Associates HEA - Gramercy Location Houston Texas 77025 —
Advanced Laser Vision Surgical Institute (Study Site) Intouch Clinical Research Center (SMO) Houston Texas 77034 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03982368, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 19, 2024 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03982368 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →